Key Facts Surrounding This News Item
- NITE had returned +10.37% year-to-date leading up to today’s news, versus a +2.26% return from the benchmark S&P 500 during the same period.
More Info About Nightstar Therapeutics plc (NITE)
Nightstar Therapeutics Limited, a clinical-stage gene therapy company, focuses on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases. The company was founded in 2013 and is based in London, the United Kingdom. View our full NITE ticker page with ratings, news, and more.